mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |